Legal & General Group
GRTX

Legal & General Group’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Legal & General Group’s Portfolio GRTX Stock Details GRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-984
Closed -$9K – 3685
2021
Q1 		$9K Sell
984
-72
-7% -$791 ﹤0.01% 3412
2020
Q4 		$11K Hold
1,056
– – ﹤0.01% 3320
2020
Q3 		$10K Sell
1,056
-365
-26% -$2.89K ﹤0.01% 3241
2020
Q2 		$10K Buy
1,421
+1,343
+1,722% +$14.3K ﹤0.01% 3316
2020
Q1 		$1K Buy
+78
New +$1K ﹤0.01% 3346

Other funds holding GRTX

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Legal & General Group's GRTX Position: Q2 2021 in Review

Legal & General Group sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q2 2021, closing a stake of 984 shares — an estimated $9K sold.

Legal & General Group first reported a position in GRTX in Q1 2020 and held it in 5 quarters. The position peaked at $11K in Q4 2020. 47 funds tracked by Wall St. Rank hold GRTX as of Q2 2021.

  • Legal & General Group reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Legal & General Group sold 984 Galera Therapeutics, Inc. Common Stock shares in Q2 2021, an estimated $9K.
  • Legal & General Group first reported a position in Galera Therapeutics, Inc. Common Stock in Q1 2020 and held it in 5 quarters.
  • Legal & General Group's Galera Therapeutics, Inc. Common Stock position peaked at $11K in Q4 2020.
  • 47 funds tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q2 2021.

Based on Legal & General Group's 13F filing for Q2 2021, filed 12 Aug 2021.